Geographical disparities of rectal cancer local recurrence and outcomes: A population-based analysis

Diseases of the Colon and Rectum

Volumn 56, Issue 7, 2013, Pages 850-858

  Helewa, Ramzi M ^a   Turner, Donna ^a,b   Wirtzfeld, Debrah ^a,b   Park, Jason ^a   Hochman, David J ^a   Czaykowski, Piotr ^a,b   Ahmed, Shahida ^b   Shu, Emma ^b   McKay, Andrew ^a  

^a UNIVERSITY OF MANITOBA   (Canada)

^b CANCERCARE MANITOBA   (Canada)

Author keywords

Geography; Local recurrence; Quality of care; Rectal cancer

Indexed keywords

ANTINEOPLASTIC AGENT;

ADULT; AGED; ANUS CANCER; ARTICLE; CANADA; CANCER ADJUVANT THERAPY; CANCER MORTALITY; CANCER RADIOTHERAPY; CANCER RECURRENCE; CANCER SURVIVAL; FEMALE; GEOGRAPHIC DISTRIBUTION; HUMAN; MAJOR CLINICAL STUDY; MALE; MEDICAL RECORD REVIEW; OUTCOME ASSESSMENT; OVERALL SURVIVAL; POPULATION RESEARCH; RECTUM CANCER; RECURRENCE RISK; RETROSPECTIVE STUDY; RURAL POPULATION; SURGICAL TECHNIQUE; SURVIVAL RATE; SURVIVAL TIME;

ADULT; AGED; AGED, 80 AND OVER; COMBINED MODALITY THERAPY; FEMALE; HUMANS; INCIDENCE; MALE; MANITOBA; MIDDLE AGED; NEOPLASM RECURRENCE, LOCAL; POPULATION SURVEILLANCE; RECTAL NEOPLASMS; RETROSPECTIVE STUDIES; RISK ASSESSMENT; RISK FACTORS; SURVIVAL RATE;

EID: 84879190117     PISSN: 00123706     EISSN: 15300358     Source Type: Journal    
DOI: 10.1097/DCR.0b013e31828e15cb     Document Type: Article

References (24)

1. Sebag-Montefiore D, Stephens RJ, Steele R, et al. Preoperative radiotherapy versus selective postoperative chemoradiotherapy in patients with rectal cancer (MRC CR07 and NCIC-CTG C016): a multicentre, randomised trial. Lancet. 2009;373:811-820.
2. Chari RS, Tyler DS, Anscher MS, et al. Preoperative radiation and chemotherapy in the treatment of adenocarcinoma of the rectum. Ann Surg. 1995;221:778-786.
3. Vergara-Fernandez O, Swallow CJ, Victor JC, et al. Assessing outcomes following surgery for colorectal cancer using quality of care indicators. Can J Surg. 2010;53:232-240.
4. Latosinsky S, Turner D. Local recurrence after rectal cancer treatment in Manitoba. Can J Surg. 2009;52:45-50.
5. Phang PT, MacFarlane JK, Taylor RH, et al. Effects of positive resection margin and tumor distance from anus on rectal cancer treatment outcomes. Am J Surg. 2002;183:504-508.
6. Phang PT, McGahan CE, McGregor G, et al. Effects of change in rectal cancer management on outcomes in British Columbia. Can J Surg. 2010;53:225-231.
7. Phang PT, Woods R, Brown CJ, Raval M, Cheifetz R, Kennecke H. Effect of systematic education courses on rectal cancer treatments in a population. Am J Surg. 2011;201:640-644.
8. Manitoba Health and Healthy Living Annual Statistics 2008- 2009. Available at: http://www.gov.mb.ca/health/annstats/as0809.pdf. Accessed December 17, 2012.
9. CancerCare Manitoba About Us. Available at: http://cancercare. mb.ca/home/about-us/. Accessed December 8, 2012.
10. Province of Manitoba Reporting of Diseases and Conditions Regulation, The Public Health Act. Available at: http://web2.gov. mb.ca/laws/regs/pdf/p210-037. 09.pdf. Accessed December 17, 2012.
11. Edge SB, American Joint Committee on Cancer. AJCC Cancer Staging Manual. 7th ed. New York: Springer; 2010.
12. Singh H, De Coster C, Shu E, et al. Wait times from presentation to treatment for colorectal cancer: a population-based study. Can J Gastroenterol. 2010;24:33-39.
13. Copeland G, Lake A, Firth R, et al. Cancer in North America: 2003-2007. Springfield, IL: North American Association of Central Cancer Registries, Inc; 2010.
14. Porter GA, Soskolne CL, Yakimets WW, Newman SC. Surgeon-related factors and outcome in rectal cancer. Ann Surg. 1998;227:157-167.
15. Charlson ME, Pompei P, Ales KL, MacKenzie CR. A new method of classifying prognostic comorbidity in longitudinal studies: development and validation. J Chronic Dis. 1987;40:373-383.
16. Jullumstrø E, Wibe A, Lydersen S, Edna TH. Violation of treatment guidelines: hazard for rectal cancer patients. Int J Colorectal Dis. 2012;27:103-109.
17. Palmer G, Martling A, Cedermark B, Holm T. A population-based study on the management and outcome in patients with locally recurrent rectal cancer. Ann Surg Oncol. 2007;14:447-454.
18. National Institute of Health. Adjuvant therapy for patients with colon and rectum cancer. Consensus Statement. 1990;8:1-25.
19. NIH consensus conference. Adjuvant therapy for patients with colon and rectal cancer. JAMA. 1990;264:1444-1450.
20. Wong RK, Berry S, Spithoff K, et al; Gastrointestinal Cancer Disease Site Group. Preoperative or postoperative therapy for stage II or II rectal cancer: an updated practice guideline. Clin Oncol (R Coll Radiol). 2010;22:265-271.
21. Kapiteijn E, Marijnen CA, Nagtegaal ID, et al; Dutch Colorectal Cancer Group. Preoperative radiotherapy combined with total mesorectal excision for resectable rectal cancer. N Engl J Med. 2001;345:638-646.
22. Sauer R, Becker H, Hohenberger W, et al; German Rectal Cancer Study Group. Preoperative versus postoperative chemoradiotherapy for rectal cancer. N Engl J Med. 2004;351: 1731-1740.
23. Chuah TK, Lee T, Wirtzfeld D, Pollett W. Management of primary rectal cancer by surgeons in Atlantic Canada: results of a regional survey. Can J Surg. 2010;53:396-402.
24. Quirke P, Durdey P, Dixon MF, Williams NS. Local recurrence of rectal adenocarcinoma due to inadequate surgical resection: histopathological study of lateral tumour spread and surgical excision. Lancet. 1986;2:996-999.